HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Philip Jochelson Selected Research

Doxepin (Mareen)

10/2011Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia.
7/2011A placebo- and active-controlled assessment of 6- and 50-mg oral doxepin on cardiac repolarization in healthy volunteers: a thorough QT evaluation.
11/2010Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia.
10/2010Efficacy and safety of doxepin 6 mg in a model of transient insomnia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Philip Jochelson Research Topics

Disease

4Sleep Initiation and Maintenance Disorders (Insomnia)
10/2011 - 10/2010
2Weight Gain
10/2011 - 11/2010
1Obstructive Sleep Apnea
10/2021
1Disorders of Excessive Somnolence (Hypersomnia)
10/2021
1Narcolepsy
10/2021
1Parkinson Disease (Parkinson's Disease)
10/2021
1Type 2 Diabetes Mellitus (MODY)
07/2015

Drug/Important Bio-Agent (IBA)

4Doxepin (Mareen)FDA LinkGeneric
10/2011 - 10/2010
2Cholinergic Antagonists (Anticholinergics)IBA
10/2011 - 11/2010
2TabletsIBA
07/2011 - 10/2010
1solriamfetolIBA
10/2021
1RanolazineFDA Link
07/2015
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
07/2015

Therapy/Procedure

1Glycemic Control
07/2015
1Therapeutics
07/2011
1Drug Therapy (Chemotherapy)
11/2010